Part 3/10:
As futuristic as it sounds, initial prototypes for this technology may be ready within 5 to 8 years, depending on early testing efforts. This leap in healthcare transcends mere medical application; it opens discussions about our perception of aging and mortality, possibly paving the way for a world where extended life is a norm rather than a dream.
Canine Longevity: A Leap for Dogs and Humans
Following a different but equally compelling trajectory, U.S. biotechnology startup Loyal introduced a revolutionary drug, LY002, aimed at improving and extending the lives of dogs. While the average lifespan of canines ranges from 10 to 13 years, this new medication could transform that, ensuring more active years.